Clinical trials are a strength for the Australian life sciences sector, however the ongoing issues of fragmentation and inefficiency within our regulatory system impacts on Australia fulfilling its true capacity and capability.
In recognition of this, the Australian Commission on Safety and Quality in Health Care (the Commission) is developing a new governance framework as a first step toward a nationally-consistent accreditation for health services undertaking clinical trials.
While initially planned for late 2018, the workshops dates have now been announced and will be held across Australia during February 2019. AusBiotech will continue working with the AusBiotech Clinical Trials Advisory Group to develop our position and provide real examples. The information gathered from the consultative workshops will be used to inform the Clinical Trials Governance Framework. The project is still projected to be delivered by mid-2019.
The Clinical Trials Governance Framework aims improve quality, efficiency and timeliness of clinical trials by reducing duplication and increasing efficiency, cohesion and productivity across the clinical trials sector.
Read more about the establishment of the clinical trials governance framework.